issues with compounded semaglutide How FDA Crackdowns Are Affecting GLP-1 Use In 2025 Compounded "semaglutide" is not FDA-approved

GLP-1s have reshaped how many people think about weight

After all, Canada has been dealing with obesity-related conditions - diabetes, osteoarthritis, sleep apnea, cardiovascular disease - at disproportionate rates for a long time, and the primary care system is already under considerable strain

Results Pre-Clinical Studies Kastin et al

With the GLP-1 trend changing the face of food as we know it, the largest food company in the world has made two major moves to combat the impact

If you're considering a GLP-1 medication or have questions about your metabolic health, please talk to your healthcare provider.

The former occurs in both sexes and the latter predominantly in untreated female control F344 rats but occasionally reported in treated rats (Tasaki et al